193 related articles for article (PubMed ID: 18625659)
21. [Giant cell arteritis and polymyalgia rheumatica presenting as subclavian artery obstruction].
Sato M; Takeda A; Hagiwara S; Mochizuki M; Minato N; Saito K; Kano S
Ryumachi; 1993 Aug; 33(4):330-4. PubMed ID: 8235915
[TBL] [Abstract][Full Text] [Related]
22. Balloon angioplasty of arteries of the upper extremities in patients with extracranial giant-cell arteritis.
Both M; Aries PM; Müller-Hülsbeck S; Jahnke T; Schäfer PJ; Gross WL; Heller M; Reuter M
Ann Rheum Dis; 2006 Sep; 65(9):1124-30. PubMed ID: 16464985
[TBL] [Abstract][Full Text] [Related]
23. Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis.
Nesher G; Berkun Y; Mates M; Baras M; Rubinow A; Sonnenblick M
Arthritis Rheum; 2004 Apr; 50(4):1332-7. PubMed ID: 15077317
[TBL] [Abstract][Full Text] [Related]
24. Involvement of peripheral arteries in giant cell arteritis: a color Doppler sonography study.
Schmidt WA; Natusch A; Möller DE; Vorpahl K; Gromnica-Ihle E
Clin Exp Rheumatol; 2002; 20(3):309-18. PubMed ID: 12102466
[TBL] [Abstract][Full Text] [Related]
25. Large-vessel giant cell arteritis: diagnosis, monitoring and management.
Koster MJ; Matteson EL; Warrington KJ
Rheumatology (Oxford); 2018 Feb; 57(suppl_2):ii32-ii42. PubMed ID: 29982778
[TBL] [Abstract][Full Text] [Related]
26. Mesenteric ischemia in giant cell arteritis: 6 cases and a systematic review.
Sujobert P; Fardet L; Marie I; Duhaut P; Cohen P; Grange C; Gaultier JB; Arrivé L; Cabane J
J Rheumatol; 2007 Aug; 34(8):1727-32. PubMed ID: 17611981
[TBL] [Abstract][Full Text] [Related]
27. [Giant cell arteritis-related upper/lower limb vasculitis].
Assie C; Marie I
Presse Med; 2011 Feb; 40(2):151-61. PubMed ID: 21239139
[TBL] [Abstract][Full Text] [Related]
28. Bilateral axillobrachial and external carotid artery manifestation of giant cell arteritis: important role of color duplex ultrasonography in the diagnosis.
Kolossváry E; Kollár A; Pintér H; Erényi E; Kiséry I; Péter H; Farkas K; Mogán L; Farsang C; Kiss I
Int Angiol; 2005 Jun; 24(2):202-5. PubMed ID: 15997226
[TBL] [Abstract][Full Text] [Related]
29. Giant cell arteritis: a systemic vascular disease.
Tatò F; Hoffmann U
Vasc Med; 2008; 13(2):127-40. PubMed ID: 18593802
[TBL] [Abstract][Full Text] [Related]
30. The predictive value of the halo sign in color Doppler ultrasonography of the temporal arteries for diagnosing giant cell arteritis.
Nesher G; Shemesh D; Mates M; Sonnenblick M; Abramowitz HB
J Rheumatol; 2002 Jun; 29(6):1224-6. PubMed ID: 12064840
[TBL] [Abstract][Full Text] [Related]
31. Giant cell arteritis: heterogeneity in clinical presentation and imaging results.
Janssen SP; Comans EH; Voskuyl AE; Wisselink W; Smulders YM
J Vasc Surg; 2008 Oct; 48(4):1025-31. PubMed ID: 18639414
[TBL] [Abstract][Full Text] [Related]
32. Prognosis and monitoring of giant cell arteritis and associated complications.
Kermani TA; Warrington KJ
Expert Rev Clin Immunol; 2018 May; 14(5):379-388. PubMed ID: 29676201
[TBL] [Abstract][Full Text] [Related]
33. Risk of ischaemic events at giant cell arteritis diagnosis according to PET/CT findings.
Mestre-Torres J; Simó-Perdigó M; Martínez-Valle F; Navales I; Loureiro-Amigo J; Solans-Laque R
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1626-1632. PubMed ID: 31081519
[TBL] [Abstract][Full Text] [Related]
34. Giant cell arteritis: diagnostic accuracy of MR imaging of superficial cranial arteries in initial diagnosis-results from a multicenter trial.
Klink T; Geiger J; Both M; Ness T; Heinzelmann S; Reinhard M; Holl-Ulrich K; Duwendag D; Vaith P; Bley TA
Radiology; 2014 Dec; 273(3):844-52. PubMed ID: 25102371
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of damage in giant cell arteritis.
Kermani TA; Sreih AG; Cuthbertson D; Carette S; Hoffman GS; Khalidi NA; Koening CL; Langford CA; McAlear CA; Monach PA; Moreland L; Pagnoux C; Seo P; Warrington KJ; Ytterberg SR; Merkel PA;
Rheumatology (Oxford); 2018 Feb; 57(2):322-328. PubMed ID: 29112740
[TBL] [Abstract][Full Text] [Related]
36. Ultrasound halo count in the differential diagnosis of atherosclerosis and large vessel giant cell arteritis.
Monjo-Henry I; Fernández-Fernández E; Mostaza JM; Lahoz C; Molina-Collada J; de Miguel E
Arthritis Res Ther; 2023 Feb; 25(1):23. PubMed ID: 36788547
[TBL] [Abstract][Full Text] [Related]
37. High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition.
Berger CT; Wolbers M; Meyer P; Daikeler T; Hess C
Rheumatology (Oxford); 2009 Mar; 48(3):258-61. PubMed ID: 19129348
[TBL] [Abstract][Full Text] [Related]
38. The fast-track ultrasound clinic for early diagnosis of giant cell arteritis significantly reduces permanent visual impairment: towards a more effective strategy to improve clinical outcome in giant cell arteritis?
Diamantopoulos AP; Haugeberg G; Lindland A; Myklebust G
Rheumatology (Oxford); 2016 Jan; 55(1):66-70. PubMed ID: 26286743
[TBL] [Abstract][Full Text] [Related]
39. Large-vessel involvement in recent-onset giant cell arteritis: a case-control colour-Doppler sonography study.
Ghinoi A; Pipitone N; Nicolini A; Boiardi L; Silingardi M; Germanò G; Salvarani C
Rheumatology (Oxford); 2012 Apr; 51(4):730-4. PubMed ID: 22179725
[TBL] [Abstract][Full Text] [Related]
40. Superior and inferior limb ischaemia in giant cell arteritis: angiography follow-up.
García Vázquez JM; Carreira JM; Seoane C; Vidal JJ
Clin Rheumatol; 1999; 18(1):61-5. PubMed ID: 10088955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
